Clear Scientific Attends 2026 American College of Emergency Physicians (ACEP) Scientific Assembly
Chicago, IL | Oct 2026
Co-founders, Shekar Shetty, Peter Howe, and Winston Henderson attended the 2026 American College of Emergency Physicians (ACEP) Scientific Assembly in Chicago from October 5–8. The conference convenes emergency medicine professionals nationwide for practice-changing education, hands-on training, research, innovation, and collaboration. The 2026 program highlights advances in emergency diagnosis and treatment, resuscitation and critical care, artificial intelligence and emerging technologies, and strategies for addressing operational pressures in emergency departments.
About Clear Scientific
Clear Scientific was co-founded in March 2019 by Professor George M. Whitesides of Harvard University with technology licensed from Massachusetts General Hospital and the University of Maryland.
Clear Scientific is pioneering a new paradigm for treatment of conditions and diseases that involve an excess of specific compounds in the body. The company is developing highly selective, small molecule sequestrants that bind, inactivate, and rapidly clear these excess compounds from the body. Clear Scientific receives funding from the National Institutes of Health (NIH) / National Institute on Drug Abuse (NIDA) and is working with their network of medical and academic professionals.
About CS-1103
CS-1103 is an investigational first-in-class injectable small molecule sequestrant that binds and inactivates target compounds, rapidly reversing their effects and accelerating their clearance into urine. The Company is initially targeting methamphetamine, fentanyl and cocaine, which are present in close to 95% of all US drug related fatalities. Clear Scientific's pipeline includes indications in central nervous system (CNS), metabolic diseases, amongst others.
For more information, visit https://www.clearsci.com
Comments